Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast normalization of oligonucleotide arrays.

Magnus Astrand1

  • 1Statistical and Mathematical Science, AstraZeneca R & D Mölndal, S-431 83 Mölndal, Sweden. magnus.astrand@astrazeneca.com

Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|April 5, 2003
PubMed
Summary

This study introduces a novel nonlinear normalization method for Affymetrix high-density oligonucleotide arrays. This approach enhances direct array-to-array comparisons by focusing on feature intensity normalization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Canadian journal of physiology and pharmacology·2026
Same author

The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans.

Molecular therapy. Advances·2026
Same author

Phase 2b trial of an oral relaxin family peptide receptor 1 agonist in patients with chronic heart failure: rationale and design.

ESC heart failure·2026
Same author

Population Pharmacokinetic Analysis of Balcinrenone in Healthy Participants and Participants with Heart Failure and Chronic Kidney Disease.

Clinical pharmacokinetics·2025
Same author

Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD.

Journal of the American Society of Nephrology : JASN·2024
Same author

Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease.

British journal of clinical pharmacology·2024

Failed At:

2026-06-19T13:35:39.166154+00:00

Related Experiment Videos